A team of scientists at the University of Seville has identified an essential process that protects DNA integrity in reproductive cells, providing new clues about how organisms avoid genetic defects ...
The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by chemist Brian Liau and his collaborators at Harvard offers an ...
Hosted on MSN
How Technology Is Shaping the Future of Our Senses
A fascinating exploration into how the future of senses will revolutionize the way we experience the world, from augmented reality to sensory enhancements that could change human perception forever.
Broad restrictions could cause supply interruptions for arms makers, as well as manufacturers in the semiconductor, automotive and other sectors. By Keith Bradsher Reporting from Shanghai From cars ...
In a video shared on the social media platform X on Thursday, the investor shared his thoughts on the probe into Tesla. "I don't think that they're [NHTSA] going after Tesla per se," the investor said ...
They’re getting an A in AI. A Catholic high school on Long Island is teaming up with a nationally recognized law school to enhance artificial intelligence learning for teenagers, enabling them to ...
Oct 6 (Reuters) - AstraZeneca (AZN.L), opens new tab has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The ...
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...
Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...
New research has filled in missing links between gene variants that have been implicated in disease through genome-wide association studies and how the variants drive disease pathology. The research ...
Stellantis NV has pulled back plans to launch a Level 3 autonomous driving platform in its vehicles, saying there's a limited market for the technology. The transatlantic carmaker in February said it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback